MedTrace Logo

The Effects of Study Products Containing Varying Quantities of Docosahexaenoic Acid (DHA)

NCT01174134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-09-02

No results posted yet for this study

Summary

The clinical trial will provide a milk-based drink with constant amounts of nutrients but differing amount of Docosahexaenoic Acid (DHA).

Conditions

  • Levels of DHA in the Blood

Interventions

OTHER

Nutritional beverage

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Susan Carlson, Ph.D. · University of Kansas

Eligibility

Min Age
18 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174134 on ClinicalTrials.gov